A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Clinical trial NCT05037929 · COMPLETED
Trial details
- NCT number
- NCT05037929
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2025-02-24
- Enrollment
- 1334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.